Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood
- PMID: 28465744
- PMCID: PMC5394445
Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood
References
-
- Hook EB, Cross PK, Schreinemachers DM - Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA. 1983;249:2034. - PubMed
-
- Haraldsdottir KR, Gottfredsdottir H, Geirsson RT - CarcinomaFetal loss after amniocentesis and chorionic villus sampling in Iceland. Laeknabladid. 2014;100:147–151. - PubMed
-
- Nicolaides KH - Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7–15. - PubMed
-
- Bischoff FZ, Lewis DE, Simpson JL - Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update. 2005;11:59–67. - PubMed
-
- Lo YM, Corbetta N, Chamberlain PF, et al. - Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;16:350–485. - PubMed
LinkOut - more resources
Full Text Sources